(IFX) Infineon Technologies - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE0006231004
Stock: Microcontrollers, Power Modules, Sensors, Security Controllers
Total Rating 62
Risk 94
Buy Signal 0.67
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.91% |
| Yield on Cost 5y | 2.08% |
| Yield CAGR 5y | 12.31% |
| Payout Consistency | 58.6% |
| Payout Ratio | 56.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.2% |
| Relative Tail Risk | -2.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | 4.90 |
| Character TTM | |
|---|---|
| Beta | 0.575 |
| Beta Downside | 0.708 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.93% |
| CAGR/Max DD | 0.22 |
Description: IFX Infineon Technologies January 28, 2026
Infineon Technologies AG (XETRA:IFX) designs, manufactures, and sells a broad portfolio of semiconductor products across four operating segments: Automotive, Green Industrial Power, Power & Sensor Systems, and Connected Secure Systems. The company serves global end-markets-including automotive safety, powertrain, industrial drives, IoT, and secure connectivity-from its headquarters in Neubiberg, Germany.
Key recent metrics (FY 2025): revenue of €12.5 bn (up 8 % YoY), operating margin of 15 %, and free-cash-flow conversion of 70 %. The automotive power-semiconductor market, a core growth driver, is expanding at ~12 % annualised, while the global silicon-carbide (SiC) market is projected to grow at a 30 % CAGR through 2028, positioning Infineon’s SiC product line for outsized upside. Macro-level catalysts include the EU’s €43 bn “Important Projects of Common European Interest” (IPCEI) semiconductor funding and the U.S. CHIPS Act, both of which aim to alleviate supply-chain bottlenecks that have historically constrained the sector.
If you want a data-rich, sector-adjusted valuation to gauge Infineon’s upside, the ValueRay platform offers a concise analytical framework worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.11 > 1.0 |
| NWC/Revenue: 27.65% < 20% (prev 33.53%; Δ -5.88% < -1%) |
| CFO/TA 0.10 > 3% & CFO 3.09b > Net Income 1.02b |
| Net Debt (6.99b) to EBITDA (3.55b): 1.97 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.31b) vs 12m ago 0.46% < -2% |
| Gross Margin: 39.41% > 18% (prev 0.40%; Δ 3902 % > 0.5%) |
| Asset Turnover: 49.28% > 50% (prev 49.37%; Δ -0.09% > 0%) |
| Interest Coverage Ratio: 6.30 > 6 (EBITDA TTM 3.55b / Interest Expense TTM 261.0m) |
Altman Z'' 2.83
| A: 0.13 (Total Current Assets 9.83b - Total Current Liabilities 5.71b) / Total Assets 30.74b |
| B: 0.26 (Retained Earnings 7.87b / Total Assets 30.74b) |
| C: 0.05 (EBIT TTM 1.65b / Avg Total Assets 30.23b) |
| D: 0.72 (Book Value of Equity 9.98b / Total Liabilities 13.90b) |
| Altman-Z'' Score: 2.83 = A |
Beneish M -3.06
| DSRI: 0.98 (Receivables 2.17b/2.17b, Revenue 14.90b/14.68b) |
| GMI: 1.00 (GM 39.41% / 39.61%) |
| AQI: 1.06 (AQ_t 0.40 / AQ_t-1 0.37) |
| SGI: 1.02 (Revenue 14.90b / 14.68b) |
| TATA: -0.07 (NI 1.02b - CFO 3.09b) / TA 30.74b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of IFX shares?
As of February 10, 2026, the stock is trading at EUR 41.99 with a total of 3,650,822 shares traded.
Over the past week, the price has changed by +0.26%, over one month by +1.06%, over three months by +25.93% and over the past year by +15.73%.
Over the past week, the price has changed by +0.26%, over one month by +1.06%, over three months by +25.93% and over the past year by +15.73%.
Is IFX a buy, sell or hold?
Infineon Technologies has no consensus analysts rating.
What are the forecasts/targets for the IFX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.3 | 15% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 43.8 | 4.3% |
IFX Fundamental Data Overview February 07, 2026
Market Cap USD = 63.77b (53.92b EUR * 1.1827 EUR.USD)
P/E Trailing = 53.7727
P/E Forward = 24.7525
P/S = 3.6185
P/B = 3.0088
P/EG = 0.6812
Revenue TTM = 14.90b EUR
EBIT TTM = 1.65b EUR
EBITDA TTM = 3.55b EUR
Long Term Debt = 5.78b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.22b EUR (from shortTermDebt, last quarter)
Debt = 8.23b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.99b EUR (from netDebt column, last quarter)
Enterprise Value = 60.29b EUR (53.92b + Debt 8.23b - CCE 1.85b)
Interest Coverage Ratio = 6.30 (Ebit TTM 1.65b / Interest Expense TTM 261.0m)
EV/FCF = 44.96x (Enterprise Value 60.29b / FCF TTM 1.34b)
FCF Yield = 2.22% (FCF TTM 1.34b / Enterprise Value 60.29b)
FCF Margin = 9.00% (FCF TTM 1.34b / Revenue TTM 14.90b)
Net Margin = 6.87% (Net Income TTM 1.02b / Revenue TTM 14.90b)
Gross Margin = 39.41% ((Revenue TTM 14.90b - Cost of Revenue TTM 9.03b) / Revenue TTM)
Gross Margin QoQ = 39.92% (prev 38.14%)
Tobins Q-Ratio = 1.96 (Enterprise Value 60.29b / Total Assets 30.74b)
Interest Expense / Debt = 0.89% (Interest Expense 73.0m / Debt 8.23b)
Taxrate = 24.26% (82.0m / 338.0m)
NOPAT = 1.25b (EBIT 1.65b * (1 - 24.26%))
Current Ratio = 1.72 (Total Current Assets 9.83b / Total Current Liabilities 5.71b)
Debt / Equity = 0.49 (Debt 8.23b / totalStockholderEquity, last quarter 16.84b)
Debt / EBITDA = 1.97 (Net Debt 6.99b / EBITDA 3.55b)
Debt / FCF = 5.21 (Net Debt 6.99b / FCF TTM 1.34b)
Total Stockholder Equity = 16.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.39% (Net Income 1.02b / Total Assets 30.74b)
RoE = 6.05% (Net Income TTM 1.02b / Total Stockholder Equity 16.93b)
RoCE = 7.24% (EBIT 1.65b / Capital Employed (Equity 16.93b + L.T.Debt 5.78b))
RoIC = 5.39% (NOPAT 1.25b / Invested Capital 23.12b)
WACC = 7.06% (E(53.92b)/V(62.14b) * Re(8.03%) + D(8.23b)/V(62.14b) * Rd(0.89%) * (1-Tc(0.24)))
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF Debug] Terminal Value 80.17% ; FCFF base≈1.07b ; Y1≈960.1m ; Y5≈815.2m
Fair Price DCF = 8.38 (EV 17.90b - Net Debt 6.99b = Equity 10.91b / Shares 1.30b; r=7.06% [WACC]; 5y FCF grow -12.91% → 2.90% )
EPS Correlation: -60.78 | EPS CAGR: -5.92% | SUE: 0.05 | # QB: 0
Revenue Correlation: -12.59 | Revenue CAGR: 2.83% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-09-30): EPS=1.63 | Chg30d=+0.002 | Revisions Net=+6 | Growth EPS=+17.2% | Growth Revenue=+7.5%
EPS next Year (2027-09-30): EPS=2.26 | Chg30d=+0.032 | Revisions Net=+7 | Growth EPS=+38.9% | Growth Revenue=+12.7%
P/E Trailing = 53.7727
P/E Forward = 24.7525
P/S = 3.6185
P/B = 3.0088
P/EG = 0.6812
Revenue TTM = 14.90b EUR
EBIT TTM = 1.65b EUR
EBITDA TTM = 3.55b EUR
Long Term Debt = 5.78b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.22b EUR (from shortTermDebt, last quarter)
Debt = 8.23b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.99b EUR (from netDebt column, last quarter)
Enterprise Value = 60.29b EUR (53.92b + Debt 8.23b - CCE 1.85b)
Interest Coverage Ratio = 6.30 (Ebit TTM 1.65b / Interest Expense TTM 261.0m)
EV/FCF = 44.96x (Enterprise Value 60.29b / FCF TTM 1.34b)
FCF Yield = 2.22% (FCF TTM 1.34b / Enterprise Value 60.29b)
FCF Margin = 9.00% (FCF TTM 1.34b / Revenue TTM 14.90b)
Net Margin = 6.87% (Net Income TTM 1.02b / Revenue TTM 14.90b)
Gross Margin = 39.41% ((Revenue TTM 14.90b - Cost of Revenue TTM 9.03b) / Revenue TTM)
Gross Margin QoQ = 39.92% (prev 38.14%)
Tobins Q-Ratio = 1.96 (Enterprise Value 60.29b / Total Assets 30.74b)
Interest Expense / Debt = 0.89% (Interest Expense 73.0m / Debt 8.23b)
Taxrate = 24.26% (82.0m / 338.0m)
NOPAT = 1.25b (EBIT 1.65b * (1 - 24.26%))
Current Ratio = 1.72 (Total Current Assets 9.83b / Total Current Liabilities 5.71b)
Debt / Equity = 0.49 (Debt 8.23b / totalStockholderEquity, last quarter 16.84b)
Debt / EBITDA = 1.97 (Net Debt 6.99b / EBITDA 3.55b)
Debt / FCF = 5.21 (Net Debt 6.99b / FCF TTM 1.34b)
Total Stockholder Equity = 16.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.39% (Net Income 1.02b / Total Assets 30.74b)
RoE = 6.05% (Net Income TTM 1.02b / Total Stockholder Equity 16.93b)
RoCE = 7.24% (EBIT 1.65b / Capital Employed (Equity 16.93b + L.T.Debt 5.78b))
RoIC = 5.39% (NOPAT 1.25b / Invested Capital 23.12b)
WACC = 7.06% (E(53.92b)/V(62.14b) * Re(8.03%) + D(8.23b)/V(62.14b) * Rd(0.89%) * (1-Tc(0.24)))
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF Debug] Terminal Value 80.17% ; FCFF base≈1.07b ; Y1≈960.1m ; Y5≈815.2m
Fair Price DCF = 8.38 (EV 17.90b - Net Debt 6.99b = Equity 10.91b / Shares 1.30b; r=7.06% [WACC]; 5y FCF grow -12.91% → 2.90% )
EPS Correlation: -60.78 | EPS CAGR: -5.92% | SUE: 0.05 | # QB: 0
Revenue Correlation: -12.59 | Revenue CAGR: 2.83% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-09-30): EPS=1.63 | Chg30d=+0.002 | Revisions Net=+6 | Growth EPS=+17.2% | Growth Revenue=+7.5%
EPS next Year (2027-09-30): EPS=2.26 | Chg30d=+0.032 | Revisions Net=+7 | Growth EPS=+38.9% | Growth Revenue=+12.7%